Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis.

Saved in:
Bibliographic Details
Title: Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis.
Authors: Merola JF; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Butler DC; Department of Dermatology, University of California, San Francisco., Mark T; LEO Pharma A/S, Ballerup, Denmark., Schneider S; LEO Pharma Inc, Madison, New Jersey., Kim Y; LEO Pharma Inc, Madison, New Jersey., Abuabara K; Department of Dermatology, University of California, San Francisco.
Source: JAMA dermatology [JAMA Dermatol] 2023 Oct 01; Vol. 159 (10), pp. 1119-1123.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2023.2626